Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study

Introduction: Venous thromboembolism (VTE) is the primary cause of preventable death in hospitalized patients in the United States. This is a cross-sectional study with a brief cost analysis of thromboprophylaxis with rivaroxaban and enoxaparin in acutely ill medical inpatients. Methods: The study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenci Marques, Gustavo, De Franca, Ana Carolina, Saito, Ana Carolina, Hornung, Fabiana L, Motter, Ana Carolina, Falzoni Pontello, Ana Carolina, Fontana, Helena, Gasparetto, Juliano, Zequinão, Tiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262521/
https://www.ncbi.nlm.nih.gov/pubmed/34268028
http://dx.doi.org/10.7759/cureus.15497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262521/
https://www.ncbi.nlm.nih.gov/pubmed/34268028
http://dx.doi.org/10.7759/cureus.15497

Ejemplares similares